EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 111 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,846,000 | +1361.5% | 125,800 | +1170.7% | 0.04% | +1333.3% |
| Q3 2017 | $400,000 | -9.7% | 9,900 | -26.7% | 0.00% | -25.0% |
| Q4 2016 | $443,000 | -86.5% | 13,500 | -87.0% | 0.00% | -87.1% |
| Q3 2016 | $3,273,000 | -69.6% | 103,800 | -72.9% | 0.03% | -67.7% |
| Q2 2016 | $10,765,000 | +20.4% | 382,817 | +71.4% | 0.10% | 0.0% |
| Q4 2015 | $8,938,000 | +208.5% | 223,404 | +119.7% | 0.10% | +182.4% |
| Q3 2015 | $2,897,000 | -40.1% | 101,700 | -30.7% | 0.03% | -39.3% |
| Q2 2015 | $4,839,000 | -44.3% | 146,852 | -51.4% | 0.06% | -47.7% |
| Q1 2015 | $8,685,000 | -39.3% | 301,985 | -52.6% | 0.11% | -50.0% |
| Q2 2014 | $14,302,000 | -8.5% | 636,759 | +2.9% | 0.21% | -19.5% |
| Q1 2014 | $15,639,000 | +251.5% | 618,859 | +219.8% | 0.27% | +254.7% |
| Q4 2013 | $4,449,000 | +69.9% | 193,517 | +40.8% | 0.08% | +56.2% |
| Q3 2013 | $2,618,000 | +343.7% | 137,435 | +235.8% | 0.05% | +300.0% |
| Q2 2013 | $590,000 | – | 40,927 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |